<VariationArchive VariationID="194078" VariationName="NM_206965.2(FTCD):c.1366dup (p.Glu456fs)" VariationType="Duplication" Accession="VCV000194078" Version="38" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-07-15" DateCreated="2015-06-28" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="191241" VariationID="194078">
      <GeneList>
        <Gene Symbol="FTCD" FullName="formimidoyltransferase cyclodeaminase" GeneID="10841" HGNC_ID="HGNC:3974" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46136262" stop="46155579" display_start="46136262" display_stop="46155579" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NT_187626.1" start="4876" stop="14638" display_start="4876" display_stop="14638" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47556175" stop="47575480" display_start="47556175" display_stop="47575480" Strand="-" />
          </Location>
          <OMIM>606806</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_206965.2(FTCD):c.1366dup (p.Glu456fs)</Name>
      <CanonicalSPDI>NC_000021.9:46138584:CC:CCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>21q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46138584" stop="46138585" display_start="46138584" display_stop="46138585" variantLength="1" positionVCF="46138584" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47558498" stop="47558499" display_start="47558498" display_stop="47558499" variantLength="1" positionVCF="47558498" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>E456fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.47558500dup" Assembly="GRCh37">
            <Expression>NC_000021.8:g.47558500dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.46138586dup" Assembly="GRCh38">
            <Expression>NC_000021.9:g.46138586dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016191.1" sequenceAccession="NG_016191" sequenceVersion="1" change="g.21983dup">
            <Expression>NG_016191.1:g.21983dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001320412.2" sequenceAccession="NM_001320412" sequenceVersion="2" change="c.1366dup">
            <Expression>NM_001320412.2:c.1366dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001307341.1" sequenceAccession="NP_001307341" sequenceVersion="1" change="p.Glu456fs">
            <Expression>NP_001307341.1:p.Glu456fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006657.3" sequenceAccession="NM_006657" sequenceVersion="3" change="c.1366dup">
            <Expression>NM_006657.3:c.1366dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006648.1" sequenceAccession="NP_006648" sequenceVersion="1" change="p.Glu456fs">
            <Expression>NP_006648.1:p.Glu456fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_206965.2" sequenceAccession="NM_206965" sequenceVersion="2" change="c.1366dup" MANESelect="true">
            <Expression>NM_206965.2:c.1366dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_996848.1" sequenceAccession="NP_996848" sequenceVersion="1" change="p.Glu456fs">
            <Expression>NP_996848.1:p.Glu456fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006657.2" sequenceAccession="NM_006657" sequenceVersion="2" change="c.1366dupG">
            <Expression>NM_006657.2:c.1366dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA200957" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606806.0006" DB="OMIM" />
        <XRef Type="rs" ID="777099958" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_206965.2(FTCD):c.1366dup (p.Glu456fs) AND not provided" Accession="RCV000174355" Version="28">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2022-07-06" SubmissionCount="3">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206965.2(FTCD):c.1366dup (p.Glu456fs) AND Glutamate formiminotransferase deficiency" Accession="RCV001199937" Version="5">
        <ClassifiedConditionList TraitSetID="1099">
          <ClassifiedCondition DB="MedGen" ID="C0268609">Glutamate formiminotransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-13" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206965.2(FTCD):c.1366dup (p.Glu456fs) AND Inborn genetic diseases" Accession="RCV002516627" Version="3">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-13" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2015-06-28" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(3); Likely pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">29178637</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30740726</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(3); Likely pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2020-02-01">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1099" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1296" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Formiminotransferase deficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Formiminoglutamicaciduria (FIGLU-uria)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Formiminoglutamic acidemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Arakawa syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glutamate formiminotransferase deficiency</ElementValue>
                <XRef ID="59761008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Formiminoglutamic aciduria</ElementValue>
                <XRef ID="MONDO:0009240" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9279" />
                <XRef ID="9279" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Glutamate formiminotransferase deficiency is an autosomal recessive disorder and the second most common inborn error of folate metabolism. Features of a severe phenotype include elevated levels of formiminoglutamate (FIGLU) in the urine in response to histidine administration, megaloblastic anemia, and mental retardation. Features of a mild phenotype include high urinary excretion of FIGLU in the absence of histidine administration, mild developmental delay, and no hematologic abnormalities (summary by Hilton et al., 2003).</Attribute>
                <XRef Type="MIM" ID="229100" DB="OMIM" />
              </AttributeSet>
              <XRef ID="51208" DB="Orphanet" />
              <XRef ID="C0268609" DB="MedGen" />
              <XRef ID="MONDO:0009240" DB="MONDO" />
              <XRef Type="MIM" ID="229100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="413954" SubmissionDate="2016-11-03" DateLastUpdated="2015-06-28" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="22135_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000225641" DateUpdated="2015-06-28" DateCreated="2015-06-28" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-08-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation Type="general">
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="21" alternateAllele="C" referenceAllele="-" start="47558498" stop="47558499" variantLength="2" />
            <GeneLocation>NM_006657.2:Ex12</GeneLocation>
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://geneticslab.emory.edu/emvclass/emvclass.php?approved_symbol=FTCD</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL003</SubmissionName>
          <SubmissionName>EGL004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2703107" SubmissionDate="2020-07-04" DateLastUpdated="2022-07-09" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="606806.0006_GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY" title="FTCD, 1-BP DUP, NT1366_GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY" />
        <ClinVarAccession Accession="SCV001370724" DateUpdated="2022-07-09" DateCreated="2020-07-16" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 patients with glutamate formiminotransferase deficiency, Majumdar et al. (2017) identified compound heterozygosity for mutations in the FTCD gene: the recurrent c.990dupG mutation (606806.0003) and a 1-bp duplication (c.1366dup), resulting in a frameshift and a premature termination codon (Glu456GlyfsTer56). The c.1366dup variant had a frequency of 0.0001 in the ExAC database.</Attribute>
              <Citation>
                <ID Source="PubMed">29178637</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <Name>FTCD, 1-BP DUP, NT1366</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, NT1366</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606806.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7079342" SubmissionDate="2023-02-08" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="GDXSV:259023" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003798750" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Observed with a pathogenic variant in a patient and observed with a variant of uncertain significance in a patient in the published literature, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (Ahrens-Nicklas et al., 2019); Frameshift variant predicted to result in protein truncation, as the last 86 amino acids are replaced with 55 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; This variant is associated with the following publications: (PMID: 31980526, 24077912, 30740726, 29178637)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2714699</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006657.2:c.1366dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_163_20230208054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6416529" SubmissionDate="2024-04-19" DateLastUpdated="2024-05-01" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="a8848743|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003733085" DateUpdated="2024-05-01" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29178637</ID>
          </Citation>
          <Comment>The c.1366dupG (p.E456Gfs*56) alteration, located in exon 12 (coding exon 12) of the FTCD gene, consists of a duplication of G at position 1366, causing a translational frameshift with a predicted alternate stop codon after 56 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This alteration has been reported in the compound heterozygous state with a second FTCD alteration in patients with glutamate formiminotransferase deficiency (Majumdar, 2017). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006657.2:c.1366dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2744023" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="4962331|MedGen:C0268609" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001408987" DateUpdated="2024-02-14" DateCreated="2020-07-16" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29178637</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30740726</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29178637</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30740726</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu456Glyfs*56) in the FTCD gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 86 amino acid(s) of the FTCD protein. This variant is present in population databases (rs777099958, gnomAD 0.5%). This premature translational stop signal has been observed in individual(s) with glutamate formiminotransferase deficiency (PMID: 29178637, 30740726). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 194078). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant disrupts a region of the FTCD protein in which other variant(s) (p.Leu536*) have been determined to be pathogenic (PMID: 29178637, 30740726). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.47558498_47558499insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268609" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2271963" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-02-03">
        <ClinVarSubmissionID localKey="8958|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001153596" DateUpdated="2024-07-15" DateCreated="2020-02-03" Type="SCV" Version="24" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="21" alternateAllele="TC" referenceAllele="T" start="47558498" stop="47558498" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2271963" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="413954" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2744023" TraitType="Disease" MappingType="XRef" MappingValue="C0268609" MappingRef="MedGen">
        <MedGen CUI="C0268609" Name="Glutamate formiminotransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2703107" TraitType="Disease" MappingType="Name" MappingValue="GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C0268609" Name="Glutamate formiminotransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7079342" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6416529" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

